Compare Sana Biotechnology Inc (SANA) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Energy Select Sector SPDR Fund — how do they compare? Sana Biotechnology Inc trades at $2.8 (market cap $836.71M), while Energy Select Sector SPDR Fund trades at $65.14 (market cap $40.84B). The key difference: Energy Select Sector SPDR Fund is far larger — about 48.8× Sana Biotechnology Inc's market cap, and Energy Select Sector SPDR Fund is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 23 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| SANA | XLE | |
|---|---|---|
Market Cap | $836.71M | $40.84B |
Volume | 4,507,444 | 50,409,268 |
Sector | Health | — |
52-Week High | $5.92 | $65.93 |
52-Week Low | $2.68 | $42.61 |
Typical Hold Time | 23 Days | 67 Days |
Enterprise Value | $749.96M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $2.84, up 4.41% today, while showing bearish technical signals with moving averages indicating selling pressure. The company remains pre-revenue with significant losses (-$244.17M net income in 2025) and negative cash flow from operations. Recent investor conference presentations highlight ongoing development of engineered cell therapies, though earnings have missed expectations in two of the last three quarters.
Despite analyst optimism (82% buy ratings), SANA faces substantial execution risk as a clinical-stage biotech with no current revenue and high cash burn. The stock's outlook depends heavily on clinical trial progress and future funding needs, with current valuation at 5.41x book value despite negative profitability metrics.
XLE trades at $65.09, up 2.7% today amid bullish technical signals from moving averages, though oscillators show caution with RSI levels in overbought territory. The energy ETF faces mixed sentiment as oil prices surge above $100 due to Middle East tensions while futures traders bet on a potential 12% sector decline. Recent news highlights strategic oil reserve concerns and diesel price pressures affecting energy markets.
Outlook remains volatile with geopolitical risks driving short-term gains but fundamental headwinds from potential oil price corrections. Key risks include oil market volatility and Federal Reserve policy impacts, while technical support at $64-$65 provides near-term stability. Investors should weigh high current energy prices against recessionary pressures that could dampen demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
